Evidence map›Paper›PMID 36944458›Full record

ArticleBMJ open2023

Integrating contraceptive services into existing perinatal care: protocol for a community-based cluster randomised controlled trial in Shanghai, China.

Longmei Jin, Anxin Yin, Xiaohua Zhang, Hong Jiang, Lu Zhou, Xiaoyan Zhou, Xiurui Wang, Xu Qian

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Longmei Jin *Department of Woman Health Care, Minhang District Maternal and Child Health Hospital, Shanghai, China.
Anxin Yin *School of Public Health, Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.
Xiaohua ZhangDepartment of Woman Health Care, Minhang District Maternal and Child Health Hospital, Shanghai, China h_jiang@fudan.edu.cn zxh_2046@126.com.
Hong JiangSchool of Public Health, Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China h_jiang@fudan.edu.cn zxh_2046@126.com.ORCID 0000-0002-2810-8000
Lu ZhouSchool of Public Health, Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.
Xiaoyan ZhouDepartment of Woman Health Care, Minhang District Maternal and Child Health Hospital, Shanghai, China.
Xiurui WangDepartment of Woman Health Care, Minhang District Maternal and Child Health Hospital, Shanghai, China.
Xu QianSchool of Public Health, Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPostpartum contraception is essential to preventing unintended pregnancies and short interpregnancy intervals. The first year after childbirth is a critical period with a high risk of unintended pregnancy and induced abortion. However, the postpartum contraceptive services are weak in China's existing maternal and child healthcare system. We propose to evaluate the effects of integrating postpartum contraceptive services into the existing perinatal care system via a cluster randomised controlled trial. METHODS AND ANALYSIS: This cluster randomised controlled trial involves all 13 communities of Minhang District, Shanghai, China. Communities will be randomly allocated, seven in the intervention group and six in the control group. One thousand and three hundred women, 100 women in each community, will be recruited in the study. Women assigned to the intervention group will receive postpartum contraceptive education and counselling during pregnancy, childbirth hospitalisation, postpartum home visits and the 42-day postpartum clinic check-up. Women in the control group will receive routine antenatal and postpartum care. Participants will be recruited in the first trimester during pregnancy and followed up to 1 year postpartum. The primary outcome is the incidence of unintended pregnancy within 1 year after childbirth. ETHICS AND DISSEMINATION: The trial received ethical approval from the Ethics Committee of Shanghai Minhang District Maternal and Child Health Care Hospital (#[2020]KS-02, #[2020]KS-05, #[2020]KS-05-EX). Results will be published in academic journals and disseminated in multiple formats for the health professionals and the public. TRIAL REGISTRATION NUMBER: ChiCTR2000034603.

Indexed as

Contraceptive AgentsPerinatal CareChildChinaCommunity Health ServicesContraceptionFemaleHumansInfant, NewbornPregnancyRandomized Controlled Trials as TopicContraceptive AgentsCommunity gynaecologyPERINATOLOGYPREVENTIVE MEDICINEPUBLIC HEALTHReproductive medicineREPRODUCTIVE MEDICINE

Identifiers

PMID36944458
PMCPMC10032403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.